XNAS · Healthcare · Medical Devices
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | Q1 2026 | 0.47 | 0.56 | +19.15% | $1.19B | ✅ Beat | -3.36% | +2.28% | +23.83% |
| 2026-02-12 | Q4 2025 | 0.65 | 0.68 | +4.62% | $1.26B | ✅ Beat | -1.12% | +11.05% | -1.29% |
| 2025-10-30 |
| Q3 2025 |
| 0.57 |
| 0.61 |
| +7.02% |
| $1.21B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-07-30 | Q2 2025 | 0.45 | 0.48 | +6.67% | $1.16B | ✅ Beat | — | — | — |
| 2025-05-01 | Q1 2025 | 0.33 | 0.32 | -3.03% | $1.04B | ❌ Miss | — | — | — |
| 2025-02-13 | Q4 2024 | 0.50 | 0.45 | -10.00% | $1.11B | ❌ Miss | — | — | — |
| 2024-10-24 | Q3 2024 | 0.43 | 0.45 | +4.65% | $994.2M | ✅ Beat | — | — | — |
| 2024-07-25 | Q2 2024 | 0.39 | 0.43 | +10.26% | $1.00B | ✅ Beat | — | — | — |
Showing last 8 quarters.